Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for emergence delirium and postoperative behavioral changes in children undergoing tonsillectomy and adenoidectomy
ChiCTR2300069033Phase 4Completed
- Sponsor
- Fujian Provincial Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Emergence agitation (EA), Postoperative maladaptive behavioral changes (PMBC) and postoperative pain comparing Esketamine group with Control group (normal saline placebo) (2 arms). Primary endpoints: Incidence of emergence delirium and Incidence of postoperative negative behaviour changes (day 7). Started Apr 2023; status: completed.
02
Drugs
esketamine
03
Conditions
Emergence agitation (EA)Postoperative maladaptive behavioral changes (PMBC)postoperative pain
Beyond the preview
Go deeper on ChiCTR2300069033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069033.